Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 15
Submit an article Journal homepage
131
Views
6
CrossRef citations to date
0
Altmetric
Review

Interaction of current cancer treatments and the immune system: implications for breast cancer therapeutics

Peng H Tan University of Oxford, The John Radcliffe Hospital, Nuffield Department of Surgery, Headley Way, Oxford, OX3 9DU, UK +44 816 522 1117; [email protected]
&
Amrit S Lota University of Oxford, The John Radcliffe Hospital, Nuffield Department of Surgery, Headley Way, Oxford, OX3 9DU, UK +44 816 522 1117; [email protected]
Pages 2639-2660 | Published online: 19 Sep 2008

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

PH Tan & AK Bharath. (2009) Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases. Expert Opinion on Therapeutic Targets 13:8, pages 987-1012.
Read now

Articles from other publishers (5)

Kenji Gonda, Masahiko Shibata, Tohru Ohtake, Yoshiko Matsumoto, Kazunoshin Tachibana, Noriko Abe, Hitoshi Ohto, Kenichi Sakurai & Seiichi Takenoshita. (2017) Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer. Oncology Letters 14:2, pages 1766-1774.
Crossref
Carmen Criscitiello & Giuseppe Curigliano. (2013) Immunotherapeutics for breast cancer. Current Opinion in Oncology 25:6, pages 602-608.
Crossref
Anu Sharma, Beata Bode, Gabriela Studer, Holger Moch, Michal Okoniewski, Alexander Knuth, Lotta von Boehmer & Maries van den Broek. (2013) Radiotherapy of Human Sarcoma Promotes an Intratumoral Immune Effector Signature. Clinical Cancer Research 19:17, pages 4843-4853.
Crossref
Min Ho Park, Ji Shin Lee & Jung Han Yoon. (2012) High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma. Journal of Surgical Oncology 106:4, pages 386-392.
Crossref
S Meraviglia, M Eberl, D Vermijlen, M Todaro, S Buccheri, G Cicero, C La Mendola, G Guggino, M D'Asaro, V Orlando, F Scarpa, A Roberts, N Caccamo, G Stassi, F Dieli & A C Hayday. (2010) In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients . Clinical and Experimental Immunology 161:2, pages 290-297.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.